Identification of clinically relevant mechanisms of resistance to endocrine therapy plus CDK4/6 inhibitors in ER+/HER2- advanced breast cancerResearch Project | 01.10.2025 - 30.09.2026 Imported from Grants Tool 4720312FundingIdentification of clinically relevant mechanisms of resistance to endocrine therapy plus CDK4/6 inhibitors in ER+/HER2- advanced breast cancerFoundations / Associations (GrantsTool), 10.2025-09.2026 (12) PI : Bentires-Alj, Mohamed.Members (1) Mohamed Bentires-AljPrincipal InvestigatorResearch Groups[FG] Bentires-Alj Mohamed
Identification of clinically relevant mechanisms of resistance to endocrine therapy plus CDK4/6 inhibitors in ER+/HER2- advanced breast cancerResearch Project | 01.10.2025 - 30.09.2026
FundingIdentification of clinically relevant mechanisms of resistance to endocrine therapy plus CDK4/6 inhibitors in ER+/HER2- advanced breast cancerFoundations / Associations (GrantsTool), 10.2025-09.2026 (12) PI : Bentires-Alj, Mohamed.
Identification of clinically relevant mechanisms of resistance to endocrine therapy plus CDK4/6 inhibitors in ER+/HER2- advanced breast cancerFoundations / Associations (GrantsTool), 10.2025-09.2026 (12) PI : Bentires-Alj, Mohamed.